Dear Doctor - Participate in the Survey on epilepsy " A new survey has found that nearly one in three people with epilepsy have experienced at least one seizure in the past year. The findings, from the Epilepsy Foundation's 2020 National Survey of Epilepsy Attitudes and Experiences, also reveal that half of all respondents worry about having a seizure in public."These survey results underscore the urgent need for improved access to care and treatments for people living with epilepsy," said Philip Gattone, CEO of the Epilepsy Foundation. "It is unacceptable that so many people with this condition are still facing challenges in getting the help they need."The survey, which was conducted online between February and March 2020, received more than 4,500 responses from people with epilepsy and their caregivers. Among other things, it found that:- 24% of respondents said they had not seen a doctor or other healthcare provider in the past year specifically for their epilepsy;- 36% said they have not been able to get all of the medication they need; and - 54% reported experiencing at least one seizure in the past year. Participate in Surveys "
1.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
2.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
3.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
4.
Year in Review: Non-Small Cell Lung Cancer
5.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
1.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
2.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
3.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
4.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
5.
The Importance of Having a Quick and Effective Heparin Antidote
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation